drugset
drugset / Trial / NCT04455555

Efficacy and Safety of Rotigotine in the Treatment of Patients With Early Stage of Primary Parkinson's Disease

NCT04455555 ↗

Phase 3 Completed 294 enrolled Peking University Third Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

The efficacy and safety of rotigotine in the treatment of patients with early stage of primary Parkinson's disease

Timeline

Start
2018-08-01
Primary completion
2019-02-01
Completion
2019-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Rotigotine Unknown — Other

Indications

Parkinson disease